EconPapers    
Economics at your fingertips  
 

Hepatitis B Immunization in a Low-incidence Province of Canada

Tim Wiebe, Patricia Fergusson, Digby Horne, Marian Shanahan, Anna Macdonald, Lynn Heise and Leslie L. Roos

Medical Decision Making, 1997, vol. 17, issue 4, 472-482

Abstract: This study provides a comparative cost-effectiveness analysis of three universal im munization programs for hepatitis B virus (HBV). Using three theoretical cohorts of infants, 10-year-olds, and 12-year-olds, a universal immunization program was com pared with a prenatal screening/newborn immunization program involving testing of prepartum women and immunization of newborns of HBsAg-positive mothers. A Mar kov long-term outcome model used Manitoba data to estimate costs and health out comes across the lifespan. The model was based on an HBV incidence rate of 19/ 100,000 and a discount rate of 5% and incorporated the most recent treatment ad vances (interferon therapy). Cost-effectiveness was calculated as the ratio of dollars spent per year of life saved, with costs determined from the perspective of a third- party payer. The universal infant-immunization program, although not cost-saving, was associated with a low, economically attractive cost-effectiveness ratio of $15,900 (Ca nadian) per year of life saved, a figure substantially lower than the ratios of $97,600 and $184,800 (Canadian) associated with the universal programs for 10- and 12-year- olds, respectively. Cost-effectiveness ratios were found to be sensitive to changes in immunization costs, HBV incidence rates, and the rate at which protective antibody levels are lost over time: If these variables move in the directions suggested by current trends, the authors anticipate an increasing economic appeal of universal programs well into the future. A universal program of HBV immunization for infants appears to be economically practical in regions where HBV infection rates are low and stable. Key words: hepatitis B; cost-effectiveness; immunization. (Med Decis Making 1997; 17:472-482)

Date: 1997
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X9701700413 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:17:y:1997:i:4:p:472-482

DOI: 10.1177/0272989X9701700413

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().

 
Page updated 2025-03-19
Handle: RePEc:sae:medema:v:17:y:1997:i:4:p:472-482